Evidence map›Paper›PMID 30805198›Full record

ArticlePilot and feasibility studies2019

Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD.

Charles Hopley, Emily Andrews, Patrick Klem, Michelle Jonjak, Ann Grothe, Patrick Ten Eyck, Zhiying You, Sarah J Billups, Corey Lyon, Korey Kennelty and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Charles Hopley1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Center, Aurora, CO USA.
Emily Andrews1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Center, Aurora, CO USA.
Patrick Klem2Kidney and Hypertension Clinic, University of Colorado Hospitals, Aurora, CO USA.
Michelle Jonjak2Kidney and Hypertension Clinic, University of Colorado Hospitals, Aurora, CO USA.
Ann Grothe2Kidney and Hypertension Clinic, University of Colorado Hospitals, Aurora, CO USA.
Patrick Ten Eyck3Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA USA.
Zhiying You1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Center, Aurora, CO USA.
Sarah J Billups4University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Center, Aurora, CO USA.
Corey Lyon5AF Williams Family Medicine Center at Stapleton, University of Colorado Anschutz Medical Center, Aurora, CO USA.
Korey Kennelty6Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City, IA USA.
Bradley Dixon8Nephrology Division, Carver College of Medicine, University of Iowa, 200 Hawkins Dr., E300C-GH, Iowa City, IA 52242 USA.
Diana Jalal8Nephrology Division, Carver College of Medicine, University of Iowa, 200 Hawkins Dr., E300C-GH, Iowa City, IA 52242 USA.ORCID 0000-0002-1975-8650
University of Colorado Anschutz Medical Campus · USUniversity of Iowa · USUniversity of Colorado Hospital · US

Funding

The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
TRAINING IN RENAL &ELECTROLYTE DISEASE &HYPERTENSIONT32DK007135 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JOHNSON, RICHARD JOSEPH, KENDRICK, JESSICA B · 1986 to 2024
$5.3M
Dissemination of the Cardiovascular Risk Service (CVRS Live)R01HL139918 · NHLBI · UNIVERSITY OF IOWA · PI KENNELTY, KOREY A · 2018 to 2022
$3.7M
NCATS NIH HHS UL1 TR002537NHLBI NIH HHS R01 HL139918NIDDK NIH HHS T32 DK007135
6 · The paper itself

Abstract

backgroundSelf-titration of blood pressure (BP) medications and lifestyle modifications are effective and safe strategies to lower BP. We assessed the feasibility of implementing a pharmacist-guided, patient-driven self-titration protocol and standardized dietary counseling to improve BP in the chronic kidney disease (CKD) clinic.

methodsAdult patients seen in the CKD clinic were identified via registry screening. Inclusion criteria were as follows: a diagnosis of hypertension, average of the last 3 office BP > 150/90 mmHg, and prescribed 3 or fewer BP medications. Patients with severe hypertension were excluded. BP goals were established and patients were referred to the clinical pharmacist who provided them a BP cuff, a BP medication titration plan (based on home BP monitoring), and dietary education. The following outcomes were evaluated: appeal of the program to patients identified by the registry, patient adherence to the protocol and 6-month office BP, and provider attitudes and acceptance of the protocol.

resultsSeventeen patients enrolled in the pilot, the majority recruited via clinic schedule screening. Eleven of the 17 patients completed a 6-month office follow-up visit. Three of the 11 patients met their pre-specified office BP goal. There was, however, significant improvement in 6-month office systolic and diastolic BP. Twelve of 17 patients were adherent to entering home BP in EMR. Provider satisfaction with the protocol was high.

conclusionOur preliminary data suggest that patient-driven self-titration of BP medications is feasible and well received by providers. Future studies are needed to validate these findings and to evaluate the safety and efficacy of this approach.

Indexed as

AdherenceBlood pressureImplementation science

Identifiers

PMID30805198
PMCPMC6373009
OpenAlexW2920175672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.